SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: margie who wrote (4496)6/15/1998 6:48:00 PM
From: Zirdu  Read Replies (3) of 6136
 
From L. Moss on AOL:

Subject: Lipid effects
Date: Mon, Jun 15, 1998 14:22 EDT
From: LMoss
Message-id: <1998061518222200.OAA24626@ladder01.news.aol.com>

I understand that data from a small study will be presented in Geneva on "buffalo hump." Patients who were using Crixivan and who developed that condition were switched to Viracept. Improvements in their condition were noted.

LMoss
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News